Ballentine Partners’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-10,673
Closed -$36.4K 908
2024
Q3
$36.4K Buy
+10,673
New +$36.4K ﹤0.01% 838